Viewing Study NCT06214793


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2025-12-25 @ 11:11 PM
Study NCT ID: NCT06214793
Status: SUSPENDED
Last Update Posted: 2025-05-01
First Post: 2024-01-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Sponsor: Megan Kruse, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module